Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)29.00
  • Today's Change1.00 / 3.57%
  • Shares traded10.00
  • 1 Year change-38.09%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income61,82345,01254,458
Depreciation/depletion39,39839,98138,398
Non-Cash items2,3982,01911,429
Cash taxes paid, supplemental9,20522,6127,109
Cash interest paid, supplemental1,5581,4841,286
Changes in working capital(47625)(88784)13,304
Total cash from operations55,994(1772)117,589
INVESTING
Capital expenditures(24823)(34559)(40467)
Other investing and cash flow items, total(498)11,83611,619
Total cash from investing(25321)(22723)(28848)
FINANCING
Financing cash flow items(477)832,317
Total cash dividends paid(45915)(45893)(45878)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net23,67221,288(5406)
Total cash from financing(22720)(24522)(48967)
NET CHANGE IN CASH
Foreign exchange effects29,3756,73521,118
Net change in cash37,328(42282)60,892
Net cash-begin balance/reserved for future use267,350309,633248,740
Net cash-end balance/reserved for future use304,678267,350309,633
SUPPLEMENTAL INCOME
Depreciation, supplemental39,39839,98138,398
Cash interest paid, supplemental1,5581,4841,286
Cash taxes paid, supplemental9,20522,6127,109
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.